Compagnie de l’Odet : Availability of the description of share buyback program
Roche’s Lunsumio and Polivy combination significantly prolongs remission for people with relapsed or refractory large B-cell lymphoma
BIC: Remuneration of Corporate Officer
Velan Inc.: Announcement
ProVen Growth and Income VCT plc: Transaction in Own Shares